61 related articles for article (PubMed ID: 25014961)
41. Adhesion of ligand-conjugated biosynthesized magnetite nanoparticles to triple negative breast cancer cells.
Obayemi JD; Hu J; Uzonwanne VO; Odusanya OS; Malatesta K; Anuku N; Soboyejo WO
J Mech Behav Biomed Mater; 2017 Apr; 68():276-286. PubMed ID: 28226310
[TBL] [Abstract][Full Text] [Related]
42. [Effects of magnetic c-erbB-2 antisense probe of different concentrations on morphology and expression of SK-Br-3 cancer cell lines in vitro].
Liu HY; Wen ZP; Wen M; He HR; Tan SD; Li SL
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2013 Feb; 35(1):19-23. PubMed ID: 23469785
[TBL] [Abstract][Full Text] [Related]
43. Immunohistochemical assay (IHC) to study C-erbB-2 status of breast cancer using monoclonal antibody CIBCgp185.
Meenakshi A; Kumar RS; Ganesh V; Sivakumar N
Hum Antibodies; 2003; 12(4):123-7. PubMed ID: 15156100
[TBL] [Abstract][Full Text] [Related]
44. Smart Bacterial Magnetic Nanoparticles for Tumor-Targeting Magnetic Resonance Imaging of HER2-Positive Breast Cancers.
Zhang Y; Ni Q; Xu C; Wan B; Geng Y; Zheng G; Yang Z; Tao J; Zhao Y; Wen J; Zhang J; Wang S; Tang Y; Li Y; Zhang Q; Liu L; Teng Z; Lu G
ACS Appl Mater Interfaces; 2019 Jan; 11(4):3654-3665. PubMed ID: 30495920
[TBL] [Abstract][Full Text] [Related]
45. Sensitivity analysis of electrical bioimpedance patterns of breast cancer cells labeled with magnetic nanoparticles: forming the foundation for a biosensor of circulating tumor cells.
González-Díaz CA; Golberg A
Physiol Meas; 2020 Jul; 41(6):064001. PubMed ID: 32413882
[TBL] [Abstract][Full Text] [Related]
46. Optimization of the Working Conditions for Magnetic Nanoparticle-Enhanced Microwave Diagnostics of Breast Cancer.
Bellizzi G; Bellizzi GG; Bucci OM; Crocco L; Helbig M; Ley S; Sachs J
IEEE Trans Biomed Eng; 2018 Jul; 65(7):1607-1616. PubMed ID: 28922111
[TBL] [Abstract][Full Text] [Related]
47. Functionalized magnetic nanoparticles for the detection and quantitative analysis of cell surface antigen.
Shahbazi-Gahrouei D; Abdolahi M; Zarkesh-Esfahani SH; Laurent S; Sermeus C; Gruettner C
Biomed Res Int; 2013; 2013():349408. PubMed ID: 23484112
[TBL] [Abstract][Full Text] [Related]
48. Note: Magnetic targeting for enhancement of the activation efficiency of G protein-coupled receptor with a two-pair coil system.
Cao Q; Han X; Chun L; Liu J; Li L
Rev Sci Instrum; 2016 Jan; 87(1):016103. PubMed ID: 26827364
[TBL] [Abstract][Full Text] [Related]
49. c-erbB-2 as a possible target for the use of magnetic nanoparticles in breast cancer cells.
Silva-Escobedo JG; Sanchez-Monroy V; Rojas-Lopez M; Lopez-Cruz J; González CA
IEEE Trans Nanobioscience; 2014 Sep; 13(3):300-7. PubMed ID: 25014961
[TBL] [Abstract][Full Text] [Related]
50. Expression of c-erbB-2 in breast cancer cell lines as experimental receptor of magnetic nanoparticles.
Silva JG; Sánchez V; Polo SM; González CA
Annu Int Conf IEEE Eng Med Biol Soc; 2013; 2013():4498-501. PubMed ID: 24110733
[TBL] [Abstract][Full Text] [Related]
51. Breast Cancer Tissue Marked Selectively by Magnetic Nanoparticles in an Experimental Animal Model.
Silva JG; Lopez J; Sánchez V; Lozano LM; González CA
J Nanosci Nanotechnol; 2015 Dec; 15(12):9591-6. PubMed ID: 26682383
[TBL] [Abstract][Full Text] [Related]
52. An intracellular anti-erbB-2 single-chain antibody is specifically cytotoxic to human breast carcinoma cells overexpressing erbB-2.
Wright M; Grim J; Deshane J; Kim M; Strong TV; Siegal GP; Curiel DT
Gene Ther; 1997 Apr; 4(4):317-22. PubMed ID: 9176517
[TBL] [Abstract][Full Text] [Related]
53. Synthesis, characterization and in vitro evaluation of exquisite targeting SPIONs-PEG-HER in HER2+ human breast cancer cells.
Almaki JH; Nasiri R; Idris A; Majid FA; Salouti M; Wong TS; Dabagh S; Marvibaigi M; Amini N
Nanotechnology; 2016 Mar; 27(10):105601. PubMed ID: 26861770
[TBL] [Abstract][Full Text] [Related]
54. Phagocytosis of breast cancer cells mediated by anti-MUC-1 monoclonal antibody, DF3, and its bispecific antibody.
Akewanlop C; Watanabe M; Singh B; Walker M; Kufe DW; Hayes DF
Cancer Res; 2001 May; 61(10):4061-5. PubMed ID: 11358826
[TBL] [Abstract][Full Text] [Related]
55.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
56.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
57.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
58.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
59.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
